137 related articles for article (PubMed ID: 20626043)
21. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities.
Castle PE; Gravitt PE; Wentzensen N; Schiffman M
Am J Clin Pathol; 2012 Aug; 138(2):241-6. PubMed ID: 22904136
[TBL] [Abstract][Full Text] [Related]
22. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
Islami F; Fedewa SA; Jemal A
Prev Med; 2019 Jun; 123():316-323. PubMed ID: 31002830
[TBL] [Abstract][Full Text] [Related]
23. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
24. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
25. Does lowering the screening age for cervical cancer in The Netherlands make sense?
van der Aa MA; de Kok IM; Siesling S; van Ballegooijen M; Coebergh JW
Int J Cancer; 2008 Sep; 123(6):1403-6. PubMed ID: 18566998
[TBL] [Abstract][Full Text] [Related]
26. Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel.
Bassal R; Schejter E; Bachar R; Shapira H; Kaufman Z; Cohen D; Keinan-Boker L
Arch Gynecol Obstet; 2015 Aug; 292(2):405-13. PubMed ID: 25690481
[TBL] [Abstract][Full Text] [Related]
27. Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.
Baldur-Felskov B; Dehlendorff C; Junge J; Munk C; Kjaer SK
Cancer Causes Control; 2014 Jul; 25(7):915-22. PubMed ID: 24797870
[TBL] [Abstract][Full Text] [Related]
28. The incidence of cervical intraepithelial neoplasia in a population of pregnant women with an abnormal cytology.
Pruski D; Malkowska-Walczak B; Paluszkiewicz A; Kędzia W
Ginekol Pol; 2017; 88(1):20-23. PubMed ID: 28157250
[TBL] [Abstract][Full Text] [Related]
29. Frequency of cervical smear abnormalities within 3 years of normal cytology.
Sawaya GF; Kerlikowske K; Lee NC; Gildengorin G; Washington AE
Obstet Gynecol; 2000 Aug; 96(2):219-23. PubMed ID: 10908766
[TBL] [Abstract][Full Text] [Related]
30. Cervical intraepithelial neoplasia (dysplasia and carcinoma in situ) and early invasive cervical carcinoma.
Nelson JH; Averette HE; Richart RM
CA Cancer J Clin; 1989; 39(3):157-78. PubMed ID: 2496898
[No Abstract] [Full Text] [Related]
31. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
[TBL] [Abstract][Full Text] [Related]
32. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
Macgregor JE; Campbell MK; Mann EM; Swanson KY
BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
[TBL] [Abstract][Full Text] [Related]
33. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
Levi F; La Vecchia C; Randimbison L; Te VC
Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
[TBL] [Abstract][Full Text] [Related]
34. Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.
Ma MJ; Wang YN; Zhu JF; Wang XY; Jin YB; Liu XN; Wu SF; Yang YB
Curr Probl Cancer; 2021 Dec; 45(6):100761. PubMed ID: 34154817
[TBL] [Abstract][Full Text] [Related]
35. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
36. Influences on the risk of recurrent high grade cervical abnormality.
Mitchell H; Hocking J
Int J Gynecol Cancer; 2002; 12(6):728-34. PubMed ID: 12445250
[TBL] [Abstract][Full Text] [Related]
37. Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III.
Rapiti E; Usel M; Neyroud-Caspar I; Merglen A; Verkooijen HM; Vlastos AT; Pache JC; Kumar N; Bouchardy C
Eur J Cancer; 2012 Apr; 48(6):845-52. PubMed ID: 21658934
[TBL] [Abstract][Full Text] [Related]
38. Underlying histopathology of HIV-infected women with squamous cell abnormalities on cervical cytology.
Suwankanta N; Kietpeerakool C; Srisomboon J; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2008; 9(3):441-4. PubMed ID: 18990018
[TBL] [Abstract][Full Text] [Related]
39. Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.
Moon EK; Oh CM; Won YJ; Lee JK; Jung KW; Cho H; Jun JK; Lim MC; Ki M
Cancer Res Treat; 2017 Apr; 49(2):526-533. PubMed ID: 27586676
[TBL] [Abstract][Full Text] [Related]
40. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme.
Bucchi L; Mancini S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; de Bianchi PS; Ferretti S;
J Med Screen; 2020 Jun; 27(2):96-104. PubMed ID: 31690178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
